Matthew Popplewell

15PUBLICATIONS
17CO-AUTHORS
Epidemiological modellingCardiology (incl. cardiovascular diseases)Medical biotechnology diagnostics (incl. biosensors)AutoimmunityMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 24, 2026
Short-term outcomes after major lower limb amputation: meta-analysis.

|Jul 01, 2026
Plain balloon angioplasty +/- bare metal stenting versus drug-coated balloon angioplasty +/- bare metal stenting versus primary drug-eluting stenting in patients with chronic limb-threatening ischaemia: BASIL-3, an open-label, three-arm, randomised, multi-centre, phase 3 trial.

|Apr 16, 2026
Interventions to Reduce Surgical Site Infection in Transmetatarsal Forefoot Amputations: A Feasibility Survey.

|Mar 04, 2026
Plain balloon angioplasty with or without bare-metal stenting versus drug-coated balloon angioplasty with or without bare-metal stenting versus primary drug-eluting stenting in patients requiring femoropopliteal, with or without infrapopliteal, endovascular revascularization for chronic limb-threatening ischaemia: BASIL-3 within-trial health economic analysis.

Mishal Javed, Jesse Kigozi, Catherine A Moakes

|Jan 31, 2026
A Systematic Review of Interventions Designed to Reduce Surgical Site Infection in Patients Who Undergo Transmetatarsal Amputation.

Rebecca Jess, Kieran Das, Lakna Harindi Alawattegama

|Nov 23, 2025
Long-term mortality rate and clinical outcomes associated with femoro-popliteal drug-coated balloon angioplasty and drug-eluting stents in chronic limb-threatening ischaemia: an analysis of the BASIL-3 RCT.

Matthew Popplewell, Jack Hall, Lewis Meecham

Pageof 3

Frequent Collaborators

6 joint publications

Lewis Meecham

5 joint publications

Andrew W Bradbury

5 joint publications

Jack Hall

5 joint publications

Gareth R Bate